{"id":"tr987-0-1-gel-standard-of-care","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Skin irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action of TR987 0.1% gel is not well-documented, but it is believed to work by augmenting the effects of standard of care through a synergistic interaction. This interaction may involve the modulation of various cellular pathways, leading to enhanced therapeutic outcomes. However, the precise molecular mechanisms underlying this interaction are not yet fully understood.","oneSentence":"TR987 0.1% gel works by targeting the existing mechanism of standard of care to enhance its effects.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:39:40.418Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of mild to moderate acne"}]},"trialDetails":[{"nctId":"NCT06707090","phase":"PHASE3","title":"Tissue Repair Gel in Venous Leg Ulcers (US)","status":"RECRUITING","sponsor":"TR Therapeutics","startDate":"2025-01-28","conditions":"Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer","enrollment":312},{"nctId":"NCT06707103","phase":"PHASE3","title":"Tissue Repair Gel in Venous Leg Ulcers in AU/US","status":"RECRUITING","sponsor":"TR Therapeutics","startDate":"2025-04","conditions":"Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer","enrollment":312}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Glucoprime"],"phase":"phase_3","status":"active","brandName":"TR987 0.1% gel + Standard of Care","genericName":"TR987 0.1% gel + Standard of Care","companyName":"TR Therapeutics","companyId":"tr-therapeutics","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TR987 0.1% gel works by targeting the existing mechanism of standard of care to enhance its effects. Used for Treatment of mild to moderate acne.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}